Charles A. Dinarello
| |
|---|---|
Charles Dinarello, 2010
| |
| Born | (1943-04-22) April 22, 1943 (age 81) |
| Nationality | American |
| Alma mater | Yale University |
| Known for | Research on inflammatory cytokines |
| Awards | Ernst Jung Prize (1993) Crafoord Prize (2009) Albany Medical Center Prize (2009) Paul Ehrlich and Ludwig Darmstaedter Prize (2010) Tang Prize (2020) |
| Scientific career | |
| Fields | Medicine Immunology |
| Institutions | University of Colorado Denver |
Charles A. Dinarello (born April 22, 1943) is a professor of medicine at the University of Colorado at Denver. He is an expert on inflammatory cytokines, specifically Interleukin 1.
Dinarello received his Doctor of Medicine in 1969 at Yale University and since 1996, he is Professor of Medicine at University of Colorado School of Medicine. He is also Professor of Experimental Medicine at the Radboud University Medical Center in Nijmegen, The Netherlands. Dinarello is considered one of the founding fathers of cytokines having purified and cloned interleukin-1.[1] This important step established the validation of cytokines as mediators of disease, particularly of inflammation. Current studies blocking IL-1 in humans supports Dinarello's and his co-workers pivotal contributions to cytokine biology and the pathogenesis of inflammatory diseases.[2]
He is fluent in English, Italian and German.[citation needed]
| International |
|
|---|---|
| National |
|
| Academics |
|
| Other |
|
   | This biographical article related to a physician in the United States is a stub. You can help Wikipedia by expanding it. |
